Migraine trials in Finland
1 trial · From EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingResearch participation
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig)
- Where
- Helsinki
- Age
- 18 years and over
- People
- 550 worldwide
- Run by
- Oslo University Hospital HF
See details and how to join2024-517981-40-00EU 2024-517981-40-00Registry updated 2026-10-07
All Migraine trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.